The differences led to significant differences in the CD4/CD8 ratio between the groups (p = 0.002), showing a higher CD4/CD8 ratio in the HT+HCsvr and HT−HCsvr groups, but with no differences between the HT+ and HT− groups. The gene discussed is CD8A; the disease is hematocrit.